Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Amedisys had a net margin of 3.57% and a return on equity of 12.20%. Sell-side analysts expect that Amedisys will post 4.4 earnings per share for the current year. Hedge Funds Weigh In On Amedisys ...

RBC Capital analyst Ben Hendrix maintained a Buy rating on Amedisys (AMED – Research Report) yesterday and set a price target of $100.00.Stay ...

Health Affairs' Jeff Byers welcomes Bob Herman of STAT News to the program to discuss the state of deals in the health care ...

The Mountain Dulcimers of Aiken will meet at 5 p.m. Tuesday, April 17, at Living Hope Fellowship Church, 2550 Old Dominion ...

The family wishes to express their sincere gratitude to the ladies who took such wonderful care of Anna Faye over the last 3 years, and to Amedisys Home Health for their loving care. Funeral ...

Staffing shortages, reimbursement cuts, staying competitive in a crowded market, the rising cost of care — if you ask ...

USAA settles class-action lawsuit over 2021 data breach affecting 22,600 members. Deadline for filing claims has passed. Victims have been notified. Settlement checks expected after final court ...

As part of Amedisys Hospice’s We Honor Veterans Program, Patricia Brewer gives Ned Melancon a Navy pin during his 100th ...